Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Obstetrics & Gynaecology (NDOG) is pleased to announce that Professor Peter Hammond, a world leader in the analysis of facial dysmorphism in rare genetic syndromes, has joined the department.

Conditions like Williams syndrome affect facial traits (shown here next to an unaffected child) © Peter Hammond
Conditions like Williams syndrome affect facial traits (shown here next to an unaffected child)

The Nuffield Department of Obstetrics & Gynaecology (NDOG) is pleased to announce that Professor Peter Hammond, a world leader in the analysis of facial dysmorphism in rare genetic syndromes, has joined the department.

Peter’s research focuses on facial development and growth in teratogenic and genetic conditions where the detection of atypical face shape is an important part of diagnosis. There are more than 700 genetic syndromes with facial traits, many of which are extremely difficult to spot because of rarity or subtlety of associated features. Face shape differences also arise from fetal exposure to alcohol and anticonvulsants. Over the last fifteen years, Peter’s lab, at University College London, pioneered sophisticated methods for computational analysis of abnormal craniofacial growth and development in humans and in animal models.  More than 10,000 3D photographic images covering healthy individuals and over 50 rare conditions were collected, often through overseas travel to visit collaborators and recruit families affected.  Through comparison with sets of faces with a known genetic disorder, candidate diagnoses can be suggested for an individual with an unknown condition. It is also possible to help identify genes causing specific facial characteristics by analysing differences between the faces of individuals with subtle variants of the same genetic anomaly. Peter will now work in collaboration with Professor Alison Noble (Institute of Biomedical Engineering) and with the INTERGROWTH 21st Project to extend the analytical techniques to 3D ultrasonography of fetal faces. 

Peter is enormously experienced and we look forward to the knowledge and expertise he will contribute to the department. 

Peter Hammond

Similar stories

INTERCOVID Study cited in the New Yorker

Fantastic news for our team who have been working on the INTERCOVID Study, which launched in April 2020. This week on 12th August 2022, the research findings cited in the New Yorker! This work was a combined effort from 43 institutions in 18 countries and involved more than two thousand pregnant women.

Women's Health Strategy for England Launched

The government has published the first ever Women's Health Strategy for England to tackle the gender health gap. Menopause, Endometriosis, Contraception and Fertility treatment are highlighted as some of the top issues women have asked for action on. The Nuffield Department of Women's & Reproductive Health welcome and fully support this bold and exciting strategy to help improve the health of millions of women in England.

Pregnancy is more likely with urine tests and timed intercourse

Dr Tatjana Gibbons leads study that suggests a woman's chance of conceiving is improved by using urine tests to detect the optimum time for intercourse, but further research is still needed to assess whether timed intercourse via any ovulation detection method creates a difference in live births and pregnancy rates.

Dawes-Redman Education awarded funds from Huntleigh Healthcare

The Dawes-Redman Education programme which offers virtual CTG Analysis training sessions to Obstetric consultants, antenatal and student midwifes has received generous funds from Huntleigh Healthcare for the next 3 years.

First UK pilot study of newborn screening for spinal muscular atrophy (SMA) launched in Oxford

Spinal muscular atrophy (SMA) is a rare, but treatable, genetic disease affecting approximately 1 in 10,000 births, and it typically presents in infancy and early childhood.

Professor Collins awarded Sir Jules Thorn Translational Biomedical Research Award 2021

Professor Sally Collins has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021 for further translational development of the OxNNet Toolkit.